WallStreetZenWallStreetZen

NASDAQ: TXMD
Therapeuticsmd Revenue

OverviewEarningsRevenue
DividendOwnership
Therapeuticsmd revenue was $3.02M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $893.0k, up 13.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TXMD annual revenue was $3.0M, with 71.6% growth year-over-year.

TXMD past revenue growth

How has TXMD's revenue growth performed historically?

Company
71.61%
Industry
4.21%
Market
89.29%
TXMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TXMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TXMD's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TXMD revenue history

Current Revenue
$3.0M
Current Earnings
-$569.0k
Current Profit Margin
-18.8%

Be the first to know when TXMD announces revenue.

TXMD Revenue History By Year

TXMD Yearly RevenueTXMD RevenueTXMD ChangeTXMD Revenue Growth
2025-12-31$3.02M$1.26M+71.61%
2024-12-31$1.76M$459.00k+35.25%
2023-12-31$1.30M-$68.66M-98.14%
2022-12-31$69.96M$67.39M+2,619.12%
2021-12-31$2.57M-$62.30M-96.03%
2020-12-31$64.87M$15.23M+30.67%
2019-12-31$49.65M$33.55M+208.38%
2018-12-31$16.10M-$678.25k-4.04%
2017-12-31$16.78M-$2.58M-13.32%
2016-12-31$19.36M-$786.45k-3.90%
2015-12-31$20.14M$5.12M+34.05%
2014-12-31$15.03M$6.25M+71.23%
2013-12-31$8.78M$4.96M+129.85%
2012-12-31$3.82M$1.73M+82.84%
2011-12-31$2.09M$846.26k+68.14%
2010-12-31$1.24MN/AN/A

1 of 2

Therapeuticsmd Revenue FAQ

What was TXMD's revenue last quarter?

On Invalid Date, Therapeuticsmd (NASDAQ: TXMD) reported Q4 2025 revenue of $893.00 thousand up 33.88% year over year. In the same quarter last year, Therapeuticsmd's revenue was $667.00 thousand.

What was Therapeuticsmd's revenue in 2025?

Therapeuticsmd's annual revenue for the twelve months ending Dec 31, 2025 was $3.02 million, a 71.61% increase year over year.

How much does Therapeuticsmd make in a day?

Based on Therapeuticsmd annual revenue for the past five years, TXMD makes an average of $43,080.00 per day.

What was Therapeuticsmd's annual revenue growth in the past year?

As of Q2 2026, Therapeuticsmd's revenue has grown 71.61% year over year. This is 67.4 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 4.21%. Therapeuticsmd's revenue in the past year totaled $3.02 million.

How much does Therapeuticsmd make in a year?

Therapeuticsmd's revenue by year for the past five years is:
  • Therapeuticsmd's revenue for the twelve months ending Dec 31, 2025 was $3.02 million, a 71.61% increase year over year.
  • Therapeuticsmd's annual revenue for Dec 31, 2024 was $1.76 million, a 35.25% increase from 2023.
  • Therapeuticsmd's annual revenue for 2023 was $1.30 million, a 98.14% decrease from 2022.
  • Therapeuticsmd's annual revenue for 2022 was $69.96 million, a 2,619.12% increase from 2021.
  • Therapeuticsmd's annual revenue for 2021 was $2.57 million, a 96.03% decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.